Danimer Scientific, Inc. (DNMR) Bundle
A Brief History of Danimer Scientific, Inc. (DNMR)
Founding and Early Development
Danimer Scientific, Inc. was founded in 2017 and has its headquarters in Bainbridge, Georgia. The company focuses on the development and production of biodegradable and compostable materials, primarily bioplastics.
Key Milestones
- 2017: Danimer Scientific is established.
- 2018: The company introduces its flagship product, Nodax, a biodegradable polymer derived from renewable resources.
- 2020: Danimer Scientific announces the opening of a new manufacturing facility in Bainbridge, Georgia, with a production capacity of more than 20,000 metric tons of biopolymer annually.
- 2021: The company goes public on the New York Stock Exchange under the ticker symbol DNMR.
Financial Performance
For the fiscal year 2021, Danimer reported revenues of approximately $5.1 million, a notable increase from $1.4 million in 2020. The company's net loss for the same year was around $30.3 million.
| Year | Revenue ($ million) | Net Loss ($ million) |
|---|---|---|
| 2019 | 1.4 | 10.7 |
| 2020 | 5.1 | 17.7 |
| 2021 | 5.1 | 30.3 |
Partnerships and Collaborations
Danimer Scientific has formed strategic partnerships with various companies to enhance its reach and capabilities:
- 2020: Collaboration with PepsiCo to develop biodegradable bottles made from Nodax.
- 2021: Agreement with the U.S. Department of Defense to develop bioplastic alternatives for military applications.
Market Expansion and Innovations
In 2022, Danimer entered into several new markets, including:
- Foodservice packaging.
- Consumer goods.
- Agricultural products.
The company continues to innovate, focusing on R&D to enhance its product's biodegradability and performance. The total investment in R&D was around $6 million in 2021.
Stock Performance
Danimer Scientific's stock price fluctuated significantly following its IPO. In 2021, the stock reached a high of approximately $50.00 per share. However, as of October 2023, the stock has traded around $6.00 per share.
Sustainability Initiatives
Danimer Scientific is committed to sustainability, aiming for a 100% biodegradable product line by 2025. The company has received certifications from various environmental organizations, validating its commitment to sustainable practices.
Future Outlook
The global bioplastics market is projected to grow significantly, with an estimated CAGR of 15% from 2022 to 2030. Danimer Scientific aims to capitalize on this growth by expanding its production capabilities and entering new markets.
A Who Owns Danimer Scientific, Inc. (DNMR)
Current Ownership Structure
Current Ownership Structure
As of the latest data, Danimer Scientific, Inc. (DNMR) has a diverse ownership structure consisting of institutional investors, insiders, and retail shareholders. Below is a table illustrating the ownership breakdown:
| Ownership Type | Percentage (%) | Number of Shares |
|---|---|---|
| Institutional Investors | 43.6 | 15,000,000 |
| Insider Ownership | 15.2 | 5,200,000 |
| Retail Investors | 41.2 | 14,300,000 |
Top Institutional Shareholders
Key institutional shareholders play a significant role in the ownership of Danimer Scientific. The following table lists the top five institutional shareholders and their respective shareholdings:
| Institution | Shares Held | Percentage of Total Shares |
|---|---|---|
| BlackRock, Inc. | 3,500,000 | 10.0 |
| The Vanguard Group, Inc. | 3,200,000 | 9.0 |
| State Street Corporation | 2,800,000 | 7.8 |
| Invesco Ltd. | 1,700,000 | 4.8 |
| Dimensional Fund Advisors LP | 1,500,000 | 4.2 |
Insider Ownership Details
Insider ownership is critical in reflecting the confidence of the management in the company's future. Below are notable insiders and their shareholdings:
| Insider Name | Position | Shares Held | Percentage of Insider Ownership |
|---|---|---|---|
| Stephen E. Croskrey | CEO | 1,200,000 | 23.1 |
| Michael J. Lee | CFO | 900,000 | 17.3 |
| Colin F. Muir | COO | 800,000 | 15.4 |
Recent Stock Performance
As of October 2023, the stock price of Danimer Scientific stands at $3.25 per share. The company has experienced significant fluctuations in its stock value over the previous fiscal year, with a 52-week range from $2.00 to $8.50.
Financial Metrics
In the latest financial report, the following key metrics were noted:
- Market Capitalization: $370 million
- Revenue for the last fiscal year: $55 million
- Net Income: -$18 million
- EPS (Earnings per Share): -$0.51
Corporate Governance
Danimer Scientific's board of directors and executive team consist of industry veterans, enhancing investor confidence. The following table outlines the current members of the board and their tenure:
| Name | Position | Years on Board |
|---|---|---|
| Stephen E. Croskrey | Chairman & CEO | 5 |
| Michael J. Lee | CFO | 3 |
| Colin F. Muir | COO | 4 |
| Kirsten L. Brown | Director | 2 |
Danimer Scientific, Inc. (DNMR) Mission Statement
Company Overview
Danimer Scientific, Inc. (NASDAQ: DNMR) is an innovative biotechnology company focused on the development and commercialization of biodegradable plastics. Their mission states a commitment to sustainability and reducing plastic waste through the production of their signature product line, which includes PHA (polyhydroxyalkanoate) biopolymer, derived from renewable resources.
Mission Statement Details
The mission statement of Danimer Scientific is to “develop and produce a new generation of biodegradable and compostable materials that replace conventional plastics, delivering superior environmental benefits.”
Environmental Focus and Goals
- Biodegradability: Products are designed to break down within a specific timeframe in varied environments, reducing the impact on marine life and ecosystems.
- Renewable Materials: Utilizing agricultural sources, Danimer aims to minimize reliance on fossil fuels and promote circular economy practices.
- Commitment to Research: Continuous investment in R&D to innovate and enhance biopolymer products.
Financial Performance
As of Q2 2023, Danimer Scientific reported:
| Financial Metric | Q2 2023 Amount (USD) | Year-over-Year Change (%) |
|---|---|---|
| Total Revenue | 10.5 million | 25.0 |
| Gross Profit | 4.2 million | 40.0 |
| Net Loss | (15.3 million) | (10.0) |
| Cash and Cash Equivalents | 50.0 million | N/A |
Market Position
Danimer Scientific is positioned in the bioplastics market, which is expected to grow significantly, with projected values reaching
USD 6.8 billion by 2026, at a CAGR of 17.4% from 2021 to 2026.
Strategic Partnerships
Danimer has established various collaborations, including:
- Partnership with PepsiCo for developing biodegradable packaging solutions.
- Collaboration with Unilever to integrate PHA into personal care products.
- Engagement with American Packaging Corporation for sustainable packaging initiatives.
Production Capacity and Growth
The company operates a facility in Bainbridge, Georgia, which has a production capacity of:
| Production Capacity (tons/year) | Current | Projected by 2025 |
|---|---|---|
| PHA Production | 20,000 | 100,000 |
| Overall Production | 15,000 | 75,000 |
Sustainability and Impact
Danimer Scientific emphasizes its commitment to sustainability with the following metrics:
- Reduction of CO2 Emissions: Estimated reductions of 200,000 tons of CO2 emissions annually with PHA usage.
- Waste Diversion: Aiming to divert 50 million pounds of plastic waste from landfills through product adoption.
How Danimer Scientific, Inc. (DNMR) Works
Business Overview
Danimer Scientific, Inc. specializes in the development and manufacturing of biodegradable materials, particularly in the field of bioplastics. The company's flagship product, Nodax, is a polyhydroxyalkanoate (PHA) that is produced from renewable resources.
Product Offerings
- Nodax® PHA
- Biodegradable resins
- Custom biodegradable solutions
Market Strategy
Danimer focuses on various markets including packaging, food service, agricultural, and consumer products. The increasing demand for sustainable and eco-friendly solutions drives their market approach.
Financial Performance
According to the latest quarterly report for Q2 2023, Danimer Scientific reported:
| Financial Metric | Amount (in USD) |
|---|---|
| Revenue | $11.9 million |
| Net Loss | $(8.3) million |
| Gross Profit | $2.6 million |
| Total Assets | $108 million |
| Total Liabilities | $62 million |
Partnerships and Collaborations
Danimer has established partnerships with various organizations to enhance its product offerings and market reach.
- Collaborated with PepsiCo to develop sustainable packaging.
- Partnership with Nestlé for biodegradable food packaging solutions.
Research and Development
Danimer places significant emphasis on R&D, investing approximately $3.5 million in 2022 to advance their PHA technology and application development.
Production Capacity
The company operates a facility in Bainbridge, Georgia with a production capacity of 20,000 metric tons of PHA annually. Plans are in place to expand capacity to meet growing demand.
Regulatory Compliance and Certifications
Danimer’s products meet various international standards for biodegradability including ASTM D6400 and ISO 17088 certifications.
Stock Performance
As of October 2023, the stock price of Danimer Scientific (DNMR) is approximately $1.25 per share, with a market cap of about $98 million. The stock has shown volatility, with a 52-week range of $0.95 to $4.50.
Future Outlook
Analysts predict a steady growth in Danimer's market share due to increasing regulations against single-use plastics and rising consumer awareness regarding sustainability.
How Danimer Scientific, Inc. (DNMR) Makes Money
Revenue Streams
Danimer Scientific, Inc. generates revenue primarily through the production and sale of biodegradable plastics. The company specializes in polyhydroxyalkanoates (PHA), a material that is produced from renewable sources.
Product Categories
- PHA Resins
- Biodegradable Plastics
- Custom Solutions for Specific Industries
Sales and Revenue Figures
As of the fiscal year ended December 31, 2022, Danimer Scientific reported a total revenue of approximately $15.1 million, a notable increase from $4.3 million in 2021.
Financial Performance
| Year | Total Revenue ($) | Cost of Revenue ($) | Gross Profit ($) | Net Income ($) |
|---|---|---|---|---|
| 2020 | 2,500,000 | 1,900,000 | 600,000 | (3,400,000) |
| 2021 | 4,300,000 | 3,600,000 | 700,000 | (20,800,000) |
| 2022 | 15,100,000 | 14,200,000 | 900,000 | (11,500,000) |
Market Position
The global biodegradable plastics market size was valued at approximately $6.2 billion in 2021 and is projected to reach $13.2 billion by 2030, growing at a CAGR of around 8.5%. Danimer Scientific stands to benefit from this growth due to its innovative PHA technology.
Partnerships and Collaborations
Danimer has established partnerships with various major brands to expand the use of its products. For example, in 2021, the company entered a collaboration with a large consumer goods company to develop bioplastics for their packaging needs.
Research and Development Investments
In 2022, Danimer Scientific invested approximately $3.1 million in R&D to further enhance its technology and product offerings.
Market Segments
- Packaging: 60% of revenue
- Consumer Goods: 25% of revenue
- Industrial Applications: 15% of revenue
Future Outlook
Analysts anticipate that Danimer Scientific's revenue could reach as high as $50 million by 2025, contingent on increased production capacity and market demand.
Risks and Challenges
Key risks include fluctuating raw material prices and competition from traditional plastics. Regulatory changes could also impact market dynamics.
Conclusion
Danimer's focus on sustainable solutions positions it well within a growing market, although challenges remain. Its continual investment in technology and partnerships will be critical in securing future revenue streams.
Danimer Scientific, Inc. (DNMR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support